Baxter International Inc 

BAX:NYSE

LastChange / % ChangeDividend YieldVolume
60.69 -0.27   -0.44%2.95%2,726,001

Market data is delayed by at least 20 minutes.
Market is closed. As of 03:59 PM ET 10/12/2012
 
 
 

Latest News Headlines for Baxter International Inc

Watch for Baxter International to Potentially Rebound After Falling 2.17% Yesterday
3 days 1 hours 40 minutes ago - Comtex Smartrend(R)
Baxter International (NYSE:BAX) traded in a range yesterday that spanned from a low of $60.24 to a high of $61.63. Yesterday, the shares fell 2.2%, which took the trading range below the 3-day low of $61.08 on volume of 3.5 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean revision.
Watch for Baxter International to Potentially Rebound After Falling 2.17% Yesterday
3 days 1 hours 41 minutes ago - Comtex Smartrend(R)
Baxter International (NYSE:BAX) traded in a range yesterday that spanned from a low of $60.24 to a high of $61.63. Yesterday, the shares fell 2.2%, which took the trading range below the 3-day low of $61.08 on volume of 3.5 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean revision.
Baxter International Makes a Move: Down 2.3%
3 days 6 hours 6 minutes ago - Financial News Network Online - Market Movers
Baxter International (NYSE:BAX) is one of today's biggest movers, down 2.3% to $60.40. The Dow Jones Industrial Average is now trading 0.6% lower to 13,496 and the S&P; is trading 0.9% lower to 1,444.
View more recent headlines
 
 
 
 
 
 
More Filings

Latest Annual and Quarterly SEC Filings

10-K
February 23, 2012
This report contains detailed information about the company's business finances and management.
10-Q
August 2, 2012
Quarterly reports contain financial statement, a discussion from management and a list of company events (stock splits, acquisitions, etc.)
 
 
 
Company Background
Baxter International Inc. (Baxter) is a global, diversified healthcare company. Baxter, through its subsidiaries, develops, manufactures and markets products that save and sustain the lives of people with hemophilia, immune disorders, infectious diseases, kidney disease, trauma, and other chronic and acute medical conditions. The Company operated in two segments: BioScience and Medication Delivery. It is engaged in the medical devices, pharmaceuticals and biotechnology to create products that advance patient care worldwide. These products are used by hospitals, kidney dialysis centers, nursing homes, rehabilitation centers, doctors' offices, clinical and medical research laboratories, and by patients at home under physician supervision. In February 2012, it acquired Synovis Life Technologies, Inc. In November 2011, it acquired Baxa Corporation. In April 2012, it purchased SIGMA International General Medical Apparatus, LLC.
Bid/Size
-- / --
Ask/Size
-- / --
Price Open
61.12
Previous Close
60.96
Day High
61.18
Day Low
60.49
52wk High/Date
61.98 / 10/5/2012
52wk Low/Date
47.5518 / 12/19/2011
Beta (5 Yr)
0.5
Market Capitalization
33.2B
Shares Outstanding
547.2M
Volatility Avg
20.07
Avg Vol(10 day)
2.5M
P/E Ratio
14.9x
EPS(TTM)
4.07
Yield
2.95%
Dividend Announcement
7/25/2012
Ex-Date
9/5/2012
Payable
0.45 - QRTR
Payable Date
10/1/2012
Date of Record
9/7/2012
 
Last Trade as of 10/12/2012 4:00 PM ET
 
 
 

BAX Baxter International Inc vs. Peers

Peers 
BAX
Baxter International Inc
23.20%
Boston Scientific Corporation
4.49%
Johnson & Johnson
3.64%
Abbott Laboratories
23.46%
Pfizer Inc.
16.08%
BAX
Baxter International Inc
2.97%
Boston Scientific Corporation
--
Johnson & Johnson
3.59%
Abbott Laboratories
2.94%
Pfizer Inc.
3.50%
BAX
Baxter International Inc
-0.44%
Boston Scientific Corporation
-0.18%
Johnson & Johnson
0.00%
Abbott Laboratories
-0.20%
Pfizer Inc.
0.00%
Compare these stocks